Brain circuits in the hypothalamus that control fear and defensive reactions

Hypothalamic prodynorphin neurocircuits integrating defensive behaviors

NIH-funded research University of Texas Hlth Sci Ctr Houston · NIH-11321713

This project looks at how a specific group of brain cells that use the chemical prodynorphin control fear and defensive reactions, with the goal of helping people with anxiety disorders and PTSD.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Texas Hlth Sci Ctr Houston NIH-funded
Lab location1 site (Houston, United States)
Project IDNIH-11321713 on NIH RePORTER

What this research studies

Researchers will map and manipulate prodynorphin-producing neurons in the paraventricular nucleus of the hypothalamus to see how they connect with other fear-related brain regions like the VMHdm and dPAG. They will use laboratory experiments in animal models with advanced circuit-mapping, genetic, and neural-activity recording tools to observe how changing these neurons shifts behavior between active fight-or-flight and passive freezing. The team will also test how these circuits respond after stress to better understand why defensive responses become inflexible in anxiety and PTSD. Overall, the work aims to link specific hypothalamic pathways and dynorphin signaling to persistent fear behaviors.

Who could benefit from this research

Good fit: This grant is preclinical and does not currently recruit patients; if translated to humans, people with anxiety disorders or PTSD would be the likely participants.

Not a fit: People without anxiety-related conditions or whose symptoms arise from non-neural causes are unlikely to receive direct benefit from this preclinical research.

Why it matters

Potential benefit: If successful, this work could reveal new biological targets for treatments that reduce excessive fear and improve symptoms in anxiety disorders and PTSD.

How similar studies have performed: Prior animal research links the dynorphin/kappa-opioid system to stress and anxiety, but applying PVH prodynorphin circuit mapping to explain defensive switching is a newer and less-tested approach.

Where this research is happening

Houston, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Anxiety Disorders
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.